VANCOUVER, B.C.—Kits Eyecare Ltd. (TSX: KITS), a leading vertically integrated eyecare provider based in Canada, has announced selected preliminary unaudited results for its second quarter ended June 30, 2026. In making the announcement, the company reported a preliminary total unaudited revenue of approximately $58.2 million, an increase of 17.3 percent year-over-year compared with the same period in 2025. Kits advised it intends to report its full second quarter 2026 results in early August with details for the second quarter conference call to be disclosed in the coming weeks.
Additional select preliminary second quarter 2026 financial highlights include the following:
• Adjusted EBITDA exceeded $2.6 million, or exceeding 4.5 percent of revenue.
• Adjusted EBITDA to exceed 4.5 percent of revenue, or exceeding $2.6 million.
• Glasses revenue expanded approximately 50.6 percent year-over-year to $10.8 million.
Kits reported that strong cash generation in the quarter drove the company’s cash balance to exceed $27.3 million at the end of the quarter, and showed no debt.
Last month, Kits announced that the Toronto Stock Exchange had accepted its notice of intention to make a normal course issuer bid (NCIB) to purchase a portion of its common shares. Under the NCIB, the company may repurchase up to 1,695,313 shares, according to the announcement, representing 5 percent of its issued and outstanding share capital. Any repurchased shares under the bid will be canceled. As of May 22, 2026, the company had 33,906,264 issued and outstanding common shares.
The company also announced two key leadership appointments in April, with the promotion of Tai Silvey to president and the promotion of Ibrahim Kamar to chief financial officer.
